GAM Holding’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

GAM Holding’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,563	Closed	-$233K	–	1000
2018 Q1	$233K	Buy	+11,563	New	+$270K	0.01%	782

Other funds holding DPLO

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

GAM Holding's DPLO Position: Q2 2018 in Review

GAM Holding sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 11,563 shares — an estimated $233K sold.

GAM Holding first reported a position in DPLO in Q1 2018 and held it in 1 quarter. The position peaked at $233K in Q1 2018. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

GAM Holding reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
GAM Holding sold 11,563 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $233K.
GAM Holding first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2018 and held it in 1 quarter.
GAM Holding's DIPLOMAT PHARMACY, INC. position peaked at $233K in Q1 2018.
206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on GAM Holding's 13F filing for Q2 2018, filed 9 Aug 2018.